Research a compound stack end to end — a structured protocol scaffold, how VialTalk researchers actually combine these compounds, receptor conflicts, and live COA-verified prices. Add 1–5 compounds.
Research signals
Redundancy, true conflicts, and dangerous additive effects
Review advised
No documented conflicts — some notes to review
Receptor activity map
| Receptor | GLOW | Glutathione | NAD+ | MOTS-c |
|---|---|---|---|---|
| VEGFR2 / angiogenesis pathway | ||||
| Actin-binding / cytoskeletal (thymosin beta-4 axis) | ||||
| Extracellular matrix / collagen synthesis (GHK-Cu axis) | ||||
| Glutathione peroxidase substrate / thiol redox buffer | ||||
| Glutathione S-transferase / Phase II detoxification | ||||
| NAD+/NADH redox carrier (electron transport) | ||||
| Sirtuin substrate axis | ||||
| PARP substrate axis (DNA repair) |
+5 more receptors
A structured, research-grounded protocol for this stack
Sign in to build a structured research protocol scaffold for NAD+ + GLOW + Glutathione + MOTS-c — phases, per-compound parameters, endpoints and washout, grounded in documented research.
What VialTalk researchers actually run
No researchers have logged this exact combination yet — yours could be the first.
Researchers are also adding
Best price for each compound today
Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.
For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.